CIK: 0001232621 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 14, 2018
Total Value ($000): $631,178 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ODONATE THERAPEUTICS INC | 12,202,338 | $305,058 | 48.3% | $25.00 | — | COM | 676079106 |
| HRTX | HERON THERAPEUTICS INC | 8,466,377 | $153,242 | 24.3% | $13.92 | +17.2% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 3,440,419 | $110,713 | 17.5% | $16.25 | — | COM | 503459604 |
| — | IGNYTA INC | 2,328,279 | $62,165 | 9.8% | $6.25 | — | COM | 451731103 |